These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Iron overload refractory to phlebotomy in a patient with type 1 hereditary hemochromatosis. Canelo-Vilaseca M, Ribera JM, Hernández-Rodríguez I. Med Clin (Barc); 2023 Apr 21; 160(8):372. PubMed ID: 36529556 [No Abstract] [Full Text] [Related]
25. [Iron overload in congenital hemolytic anemia caused by pyruvate kinase deficiency. A major late complication]. Boivin P, Galand C. Presse Med; 1990 Jun 09; 19(23):1087-90. PubMed ID: 2141411 [Abstract] [Full Text] [Related]
26. Pyruvate kinase deficient hemolytic anemia in the Northern Irish population. Percy MJ, van Wijk R, Haggan S, Savage GA, Boyd K, Dempsey S, Hamilton J, Kettle P, Kyle A, Shepherd CW, van Solinge WW, Lappin TR, McMullin MF. Blood Cells Mol Dis; 2007 Jun 09; 39(2):189-94. PubMed ID: 17574881 [Abstract] [Full Text] [Related]
27. Case report: pyruvate kinase deficiency. Rothman JM. N J Med; 1995 Sep 09; 92(9):587-8. PubMed ID: 7566675 [Abstract] [Full Text] [Related]
28. How we manage patients with pyruvate kinase deficiency. Grace RF, Mark Layton D, Barcellini W. Br J Haematol; 2019 Mar 09; 184(5):721-734. PubMed ID: 30681718 [Abstract] [Full Text] [Related]
30. Animal model of human disease: pyruvate kinase deficiency. Searcy GP, Tasker JB, Miller DR. Am J Pathol; 1979 Mar 09; 94(3):689-92. PubMed ID: 426042 [No Abstract] [Full Text] [Related]
31. Diagnosis and current treatments for primary iron overload. Brissot P. Am J Hematol; 2007 Dec 09; 82(12 Suppl):1140-1. PubMed ID: 17963250 [Abstract] [Full Text] [Related]
32. Fetal anaemia due to pyruvate kinase deficiency. Gilsanz F, Vega MA, Gómez-Castillo E, Ruiz-Balda JA, Omeñaca F. Arch Dis Child; 1993 Nov 09; 69(5 Spec No):523-4. PubMed ID: 8285758 [Abstract] [Full Text] [Related]
37. Iron overload associated with congenital pyruvate kinase deficiency and high dose ascorbic acid ingestion. Rowbotham B, Roeser HP. Aust N Z J Med; 1984 Oct 09; 14(5):667-9. PubMed ID: 6597712 [Abstract] [Full Text] [Related]
38. [Hemochromatosis--from an underdiagnosed curiosity to a common disease]. Hagve TA, Asberg A, Ulvik R, Borch-Iohnsen B, Thorstensen K. Tidsskr Nor Laegeforen; 2009 Apr 30; 129(9):863-6. PubMed ID: 19415085 [Abstract] [Full Text] [Related]
39. Severe hemochromatosis: the predominant clinical manifestation of congenital dyserythropoietic anemia type 2. Halpern Z, Rahmani R, Levo Y. Acta Haematol; 1985 Apr 30; 74(3):178-80. PubMed ID: 3938164 [Abstract] [Full Text] [Related]
40. Prevalence and management of iron overload in pyruvate kinase deficiency: report from the Pyruvate Kinase Deficiency Natural History Study. van Beers EJ, van Straaten S, Morton DH, Barcellini W, Eber SW, Glader B, Yaish HM, Chonat S, Kwiatkowski JL, Rothman JA, Sharma M, Neufeld EJ, Sheth S, Despotovic JM, Kollmar N, Pospíšilová D, Knoll CM, Kuo K, Pastore YD, Thompson AA, Newburger PE, Ravindranath Y, Wang WC, Wlodarski MW, Wang H, Holzhauer S, Breakey VR, Verhovsek M, Kunz J, McNaull MA, Rose MJ, Bradeen HA, Addonizio K, Li A, Al-Sayegh H, London WB, Grace RF. Haematologica; 2019 Feb 30; 104(2):e51-e53. PubMed ID: 30213831 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]